Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Axogen Inc (AXGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 618,264
  • Shares Outstanding, K 33,240
  • Annual Sales, $ 41,110 K
  • Annual Income, $ -14,410 K
  • 36-Month Beta 0.23
  • Price/Sales 15.08
  • Price/Cash Flow 0.00
  • Price/Book 54.62

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.60 +19.23%
on 08/23/17
19.20 -3.13%
on 09/18/17
+2.90 (+18.47%)
since 08/22/17
3-Month
14.30 +30.07%
on 08/07/17
19.20 -3.13%
on 09/18/17
+3.30 (+21.57%)
since 06/22/17
52-Week
7.65 +143.14%
on 11/09/16
19.20 -3.13%
on 09/18/17
+9.41 (+102.39%)
since 09/22/16

Most Recent Stories

More News
AxoGen, Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference

AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Karen Zaderej, President and Chief Executive Officer,...

AXGN : 18.60 (-0.27%)
AxoGen to Participate at 72nd Annual American Society for Surgery of the Hand Meeting

AxoGen Corporation (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced it will participate in the 72nd Annual Meeting...

AXGN : 18.60 (-0.27%)
AxoGen, Inc. Reports 2017 Second Quarter Financial Results

AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the second...

AXGN : 18.60 (-0.27%)
AxoGen, Inc. to Present at the Wedbush PacGrow Healthcare Conference

AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Karen Zaderej, President and Chief Executive Officer,...

AXGN : 18.60 (-0.27%)
AxoGen, Inc. Discloses Terms of Recent Equity Award

AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announced the hiring of Jon Gingrich as its Chief Commercial Officer...

AXGN : 18.60 (-0.27%)
AxoGen, Inc. to Report Second Quarter 2017 Financial Results and Host Conference Call on Wednesday, August 2, 2017

AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report second quarter 2017 financial results...

AXGN : 18.60 (-0.27%)
AxoGen, Inc. to Present at the JMP Securities Life Sciences Conference

AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Peter J. Mariani, Chief Financial Officer, will...

AXGN : 18.60 (-0.27%)
AxoGen, Inc. to Present at the Jefferies Global Healthcare Conference

AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Karen Zaderej, President and Chief Executive Officer,...

AXGN : 18.60 (-0.27%)
AxoGen (AXGN) Shows Strength: Stock Adds 6.1% in Session

AxoGen, Inc. (AXGN) shares rose a little above 6% in the last trading session.

AXGN : 18.60 (-0.27%)
CORI : 10.85 (+0.18%)
AxoGen, Inc. Reports 2017 First Quarter Financial Results

AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the first...

AXGN : 18.60 (-0.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Business Summary

AxoGen Corp. is a regenerative medicine company engaged in the development and commercialization of technologies for peripheral nerve reconstruction and regeneration. It offers products for the repair of peripheral nerve injuries. AxoGen Corp was formerly known as LecTec Corporation.

See More

Support & Resistance

2nd Resistance Point 19.00
1st Resistance Point 18.80
Last Price 18.60
1st Support Level 18.45
2nd Support Level 18.30

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.